CoverageForm 410-K10-Q8-K13D13G13F

GBCS Selectis Health, Inc. - 8-K

Filed Mar 31, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001493152-26-014113
5.02

Item 5.02 - Departure/Election of Directors or Certain Officers

59 words

ITEM
5.02

DEPARTURE
OF EXECUTIVE OFFICER AND DIRECTOR; APPOINTMENT OF EXECUTIVE OFFICER

On
March 30, 2026, David Furstenberg submitted his letter of resignation as a member of the Board of Directors and Audit Committee of Selectis
Health, Inc., a Utah corporation (the “Company”), effective immediately.

The
Company would like to thank Mr. Furstenberg for his generous service and support.